Centro Internacional de Entrenamiento e Investigaciones Medicas

What Centro Internacional de Entrenamiento e Investigaciones Medicas does

Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) is a Colombian non-profit biomedical research institution headquartered in Cali, Valle del Cauca, with a secondary clinical site in Tumaco. Founded in 1990 and rooted in a 1961 Tulane University–Universidad del Valle cooperation program, CIDEIM conducts research on infectious diseases of public health importance — primarily leishmaniasis, syphilis, tuberculosis, dengue, and emerging infections including COVID-19. The organization is structured around four research units (Clinical and Community, Laboratory, Epidemiology and Biostatistics, Social Sciences in Health) and supports specialized BSL-2+ biosafety facilities, molecular diagnostics (RT-qPCR), next-generation sequencing, omics platforms (proteomics, metabolomics, transcriptomics), immunology, microbiology, and a Leishmania biobank holding WHO reference strains.

CIDEIM's business model is grant-driven non-profit: the majority of funding flows from competitive international research grants (NIH/NIAID, Fogarty International Center, WHO/TDR, the European Commission, and Colombia's Sistema General de Regalías), supplemented by transactional revenue from diagnostic testing services (leishmaniasis, TB, SARS-CoV-2, dengue), IPS medical care for infectious disease patients at its Cali and Tumaco facilities, biobank services, and professional-services revenue from training and continuing-education programs delivered via a Moodle-based LMS and in-person formats. Customers and stakeholders include academic medical centers, schools of public health, national disease control programs, healthcare providers, and trainees across Latin America and the Caribbean.

The institution's commercial defensibility rests on a stack of exclusive WHO/PAHO designations accumulated since 1993: WHO Collaborating Centre in Leishmaniasis, WHO/TDR Regional Training Center for Latin America and the Caribbean, TDR Global Node for the Americas, and the SIHI LAC Hub. It maintains a network of international research collaborations with Yale, University of Maryland, UConn Health, UNC, Institut Pasteur, PAHO, and other partners, holds ISO 9001 accreditation in GCP/GLP, and reaches its regional audience through virtual webinars, scientific publications, and a Moodle LMS platform.

Name

Centro Internacional de Entrenamiento e Investigaciones Medicas

Legal name

Centro Internacional de Entrenamiento e Investigaciones Médicas

Website

https://cideim.org.co

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

51–100 employees

Short description

CIDEIM is a Colombian non-profit biomedical research center in Cali that investigates infectious diseases (leishmaniasis, syphilis, TB, dengue, COVID-19), delivers diagnostic services and patient care through IPS facilities, and trains researchers across Latin America and the Caribbean under WHO/TDR designations.

Ownership category

akta.pro rank

Headquarters

HQ city

Cali

HQ country

Colombia

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Research Grants and Funded Projects: CIDEIM is primarily funded through competitive international research grants from organizations such as NIH (NIAID, Fogarty), WHO/TDR, the European Commission, Colombia's Sistema General de Regalías, and other global health funders. These grants support specific research projects, training programs, and capacity-building initiatives.
2. Diagnostic Testing Services: The organization generates revenue through provision of diagnostic testing services including leishmaniasis, SARS-CoV-2 (RT-qPCR and antigen), tuberculosis (molecular diagnosis, Xpert MTB RIF/ULTRA, Xpert MTB-XDR), and dengue (NS1-IgG/IgM immunochromatographic test). Also includes biobank services such as storage, custody, PBMC separation, and strain distribution.
3. Training and Continuing Education: Revenue is generated through postgraduate elective courses, virtual training programs, and capacity-building courses (e.g., Applied Statistics in Biomedical Research, Good Clinical Practices, Implementation Research) offered to health professionals and researchers across Latin America.
4. Medical Care Services: CIDEIM provides integrated medical care for patients with infectious diseases (primarily leishmaniasis and syphilis) through its IPS (Institución Prestadora de Servicios) facility in Cali, generating revenue from patient care services.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

CIDEIM is a non-profit biomedical research center that conducts infectious disease research (leishmaniasis, syphilis, tuberculosis, dengue, malaria, Chagas disease, COVID-19), provides diagnostic testing services and biological resources management through its biobank, delivers integrated medical care for infectious disease patients at IPS facilities in Cali and Tumaco, and offers training and continuing education programs for researchers and health professionals across Latin America and the Caribbean through in-person courses and a Moodle-based virtual learning platform.

Product overview

CIDEIM is a non-profit biomedical research center specializing in infectious diseases, offering an integrated portfolio of research services, diagnostic testing, medical care, and training programs. The organization operates through four research units (Clinical and Community, Laboratory, Epidemiology and Biostatistics, and Social Sciences in Health) and provides services including medical attention, diagnostic tests for dengue, syphilis, tuberculosis, and COVID-19, and a Biological Resources Center (Biobanco). Training offerings include a Moodle-based LMS platform hosting courses in bioethics, statistics, and research methods, along with a two-year Clinical Research Fellowship program. Special programs include the SIHI LAC Hub for social innovation in health, TDR Global Node, and Regional Training Center for Latin America and the Caribbean.

Differentiator

Problem solved

Functional benefit

Brands

• LAC-RTC: Regional Training Center for Latin America and the Caribbean under TDR/WHO
• SIHI LAC Hub
• TDR Global Nodo Américas

Products and services

• Medical Care Services (Atención médica)

Quantifiable outcome

• 16 postgraduate inter-institutional courses delivered with Yale University since 2007
• +6 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

16 partnerships are on record, tiered core and minor.

• Institut PasteurcoreStrategic or Co-development Partner · 1 January 2024CIDEIM participates as the only non-European partner in the Yellow4FLAVI international consortium coordinated by Institut Pasteur and funded by the European Union (2024-2029). The project focuses on deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design, with CIDEIM researchers (María Adelaida Gómez) contributing to the multi-institutional effort alongside 12 European institutions.
• Pan American Health Organization (PAHO)coreStrategic or Co-development Partner · 1 January 2021PAHO co-leads the 2021 SIHI LAC Innovation Call with CIDEIM and the National Autonomous University of Honduras. PAHO also co-published the 2025 'Social Innovation in Health: Lessons for Advancing Equity' anthology with CIDEIM and TDR, and provides ongoing support for social innovation documentation and dissemination in the region.
• Instituto de Enfermedades Infecciosas y Parasitología Antonio Vidal (IAV, Honduras)coreStrategic or Co-development Partner · 1 January 2021IAV (Honduras) is a key collaborator in the SIHI LAC Hub alongside CIDEIM, contributing to the regional social innovation in health initiative for Latin America and the Caribbean through interdisciplinary and cross-sector collaboration.
• TDR / World Health Organization (WHO)coreStrategic or Co-development Partner · 1 January 2017CIDEIM serves as the regional node for TDR Global (since 2018), the Regional Training Center for Latin America and the Caribbean (since 2010), and the SIHI LAC Hub (since 2017) under TDR/WHO's global programs. These partnerships involve training, research capacity building, social innovation promotion, and network facilitation across Latin America and the Caribbean.
• Fundación Valle del LilicoreStrategic or Co-development Partner · 1 January 2011Collaboration on SARS-CoV-2 research since 2020, and part of a broader scientific and technological capacity strengthening alliance (CIDEIM – Fundación Valle del Lili – Universidad Icesi) funded by Colombia's Sistema General de Regalías to strengthen diagnostic and surveillance capacity for endemic and emerging diseases in Valle del Cauca.
• Universidad IcesicoreStrategic or Co-development Partner · 1 January 2008Since 2008, CIDEIM has been housed on the Universidad Icesi campus in Cali, occupying purpose-built facilities (Edificio O-CIDEIM). CIDEIM contributes teaching to Icesi's Faculty of Health Sciences and Faculty of Engineering, Design and Applied Sciences, supporting student development in chemistry, biology, and medicine programs.
• Yale UniversitycoreStrategic or Co-development Partner · 1 January 2003Since 2003, Yale University (School of Public Health) has partnered with CIDEIM through the Global Infectious Diseases (GID) Research Training Program, funded by Fogarty/NIH. The partnership involves joint research on infectious diseases, co-mentorship of researchers, and collaborative development and delivery of 16 postgraduate courses in Colombia. Collaboration extended to SARS-CoV-2 research in 2020.
• University of MarylandcoreStrategic or Co-development PartnerCIDEIM collaborates with University of Maryland on the R01AI172887 study of Leishmania Viannia persistence in naturally infected human populations (2022-2027), led by Najib El-Sayed (UM) and María Adelaida Gómez (CIDEIM). The partnership involves comparative genomics and host-pathogen interaction research.
• University of Connecticut Health CentercoreStrategic or Co-development PartnerCIDEIM collaborates with UConn Health (Salazar Laboratory and Justin Radolf) on studies of Treponema pallidum (syphilis) genomic diversity (NIAID U19AI144177, 2019-2025) and STI prevalence in Cali (NIAID U19AI144177-04). Joint work also on oral tuberculosis testing methodology.
• University of North Carolina at Chapel HillcoreStrategic or Co-development PartnerCIDEIM partners with UNC (Arlene Seña) on the Bio4S syphilis diagnostics biorepository project (2022-2025, NIAID), involving collection and characterization of specimens from syphilis patients to improve diagnostic methods.
• The University of TexasminorStrategic or Co-development PartnerListed as a collaborator on clinical and community research within CIDEIM's Clinical and Community Research Unit, with specific collaboration details available through the unit's research programs.
• University of SouthamptonminorStrategic or Co-development PartnerAcademic research collaboration in molecular biology, immunology, or genomics as part of CIDEIM's international research network, contributing to studies of infectious disease mechanisms and host-pathogen interactions.
• University of Glasgow — Glasgow PolyomicsminorStrategic or Co-development PartnerCollaboration involving advanced omics technologies (proteomics, metabolomics, transcriptomics) for CIDEIM's molecular and biochemistry research unit, providing access to high-throughput analytical platforms.
• Universidad de Los AndesminorStrategic or Co-development PartnerNational Colombian university collaboration contributing to CIDEIM's multidisciplinary research agenda, particularly in areas of computational biology, genomics, or public health research.
• Università di CataniaminorStrategic or Co-development PartnerInternational academic collaboration contributing to CIDEIM's research programs in infectious disease biology and public health, as part of the institution's broader international research network.
• Universidad del VallecoreStrategic or Co-development PartnerHistorical partnership since 1961 (the origin of CIDEIM's predecessor program). Joint doctoral programs in Health Sciences and Natural Sciences; shared faculty, student researchers, and field research sites. Continued collaboration in research and training activities.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Emerging players

• Drugs for Neglected Diseases initiative (DNDi) Latin America: Product development partnership focused on new treatments for neglected diseases including leishmaniasis and Chagas, with a Latin America office in Rio de Janeiro. Directly comparable to CIDEIM in disease focus and partnership model with WHO/endemic-country institutions, though with a drug development rather than research mandate.

Regional players

• Instituto Nacional de Salud Pública (INSP): Mexico's National Institute of Public Health, a CONACyT-affiliated research and training institution. Comparable to CIDEIM in its mission to build regional research capacity, deliver postgraduate training in epidemiology and public health, and address infectious diseases of public health importance in Latin America, though operating at significantly larger scale.

Direct peers

• Fundação Oswaldo Cruz (Fiocruz): Brazil's leading public biomedical research institution under the Ministry of Health. Like CIDEIM, Fiocruz conducts infectious disease research, operates reference laboratories and biobanks, runs postgraduate training programs, and serves as a WHO collaborating center for multiple tropical diseases in Latin America.
• Gorgas Memorial Institute of Health Studies: Panamanian government research institute focused on tropical and infectious diseases, also designated as a PAHO/WHO Collaborating Centre. Comparable to CIDEIM in mission, regional Latin American scope, integration of clinical care, laboratory diagnostics, epidemiology, and researcher training.

Broad incumbents

• Swiss Tropical and Public Health Institute: Switzerland-based institute associated with the University of Basel, combining tropical disease research, diagnostics, and postgraduate training. Comparable to CIDEIM in mission, training programs, and global health partnerships, though at substantially larger scale with broader European reach.
• Bernhard Nocht Institute for Tropical Medicine: Germany's largest institution for tropical medicine research, also serving as a WHO Collaborating Centre. Comparable to CIDEIM in BSL facilities, molecular diagnostics capability, research training programs, and tropical disease focus, though operating in a high-income country context with broader mandate.
• Texas Biomedical Research Institute: San Antonio-based nonprofit focused on infectious disease research with BSL-2/3/4 laboratories and biosafety infrastructure comparable to CIDEIM's BSL-2+ facility. Both share an NIH-funded research mandate and tropical disease focus, though Texas Biomed operates at substantially greater scale and is primate-research enabled.
• London School of Hygiene & Tropical Medicine: World-leading postgraduate institution in public and global health with major tropical disease research portfolio. Directly comparable to CIDEIM in researcher training mandate, infectious disease focus, and Fogarty/NIH-funded training collaborations, though operating at far greater scale as a degree-granting university.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/CIDEIM
• YouTubeyoutube.com/@corporacioncideim2322
• Facebookfacebook.com/cideim
• LinkedInlinkedin.com/company/cideim

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro Internacional de Entrenamiento e Investigaciones Medicas